Bausch Advances Novel Dry Eye Therapeutic to Phase 3

Quebec based B+L has announced the second of two Phase 3 studies studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a...

Read More

Novel Eye Drop to Relieve Presbyopia Enters Phase 3 Clinicals

Orasis Pharmaceuticals, an Israeli based  ophthalmic pharmaceutical company announced the start of Phase 3 clinical studies in the US to...

Read More

Survey Explores Consumers’ Motivations to Choose Contact Lenses

A survey of more than 5,000 contact lens wearers sheds light on the deeper, emotional benefits people gain from wearing contact lenses The...

Read More
University Waterloo School of Optometry

New Intervention Could Help Patients with Macular Degeneration Recover Vision

Researchers have discovered that a single, 20-minute session of non-invasive brain stimulation of the visual cortex can reduce the effects of...

Read More
Centre for Ocular Research & Education (CORE)

CORE Alerts Practitioners to Mask-Associated Dry Eye (MADE)

Widespread use of face masks has been determined essential to combat COVID-19’s spread yet is giving rise to a new phenomenon: increased reports...

Read More
1 14 15 16 17 18 51